Compare PTGX & FOIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares
Current Price
| Metric | PTGX | FOIL |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 8.6B |
| IPO Year | 2016 | 2024 |
| Metric | PTGX | FOIL |
|---|---|---|
| Price | $150.62 | $22.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $108.23 | N/A |
| AVG Volume (30 Days) | ★ 456.0K | 40.4K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $64.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.45 | $21.97 |
| 52 Week High | $160.81 | $25.44 |
| Indicator | PTGX | FOIL |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 14.60 |
| Support Level | $94.48 | $21.97 |
| Resistance Level | $160.81 | N/A |
| Average True Range (ATR) | 5.13 | 1.47 |
| MACD | -0.92 | -0.23 |
| Stochastic Oscillator | 25.63 | 5.76 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Londian Wason New Energy Tech Inc is engaged in the research, development, and manufacture of electrolytic copper foil. Its product portfolio includes lithium-ion battery (LiB) copper foil, printed circuit board (PCB)-grade copper foil, and flexible copper clad laminates (FCCLs). Its products are used in applications including electric vehicles, energy storage systems, communication equipment, and consumer electronics. The company derives its revenue from contracts with customers, including the sales of LiB copper foil, PCB-grade copper foil and others in the PRC.